CTI BioPharma (CTIC) Says FDA Full Clinical Hold On Pacritinib was Removed
Tweet Send to a Friend
CTI BioPharma Corp. (NASDAQ: CTIC) today announced that the full clinical hold (February 2016) implemented by the U.S. Food ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE